EXPLORE THE UNIVERSITY OF OXFORD'S WORLD-CLASS RESEARCH

1 - 2 of 2
1
Conference item icon
Conference item

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer

  • Holyoake, D, Wilson, J, Partridge, M, et al.
  • 2016-08-21
File available icon
Not peer reviewed icon
Link to publisher copy available icon
2
Conference item icon
Conference item

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes

  • Wilson, J, Dutton, S, Hackett, S, et al.
  • 2017-01-31
File available icon
Peer reviewed icon
Link to publisher copy available icon
FILTER RESULTS

TO TOP